Several studies that found major antipsychotic drugs to be equally or less effective than placebos went unpublished in scientific journals, were difficult to find, and omitted unfavorable data, skewing perception of the drugs’ efficacy, researchers with Oregon Health and Science University reported. –ARK

MedPage Today:

Of 24 registration trials involving eight products submitted to the FDA, four went unpublished in medical journals — three of which found that the study drug’s efficacy was equivalent to placebo or inferior to an active comparator, according to Erick H. Turner, MD, of Oregon Health and Science University in Portland, and colleagues.

Moreover, five of the 20 published trials “showed some evidence of outcome reporting bias,” the researchers wrote online in PLoS Medicine.

… “Selective reporting of research results undermines the integrity of the evidence base, which ultimately deprives clinicians of accurate data for prescribing decisions,” [researchers] wrote.

Read more

 WAIT BEFORE YOU GO...

This year, the ground feels uncertain — facts are buried and those in power are working to keep them hidden. Now more than ever, independent journalism must go beneath the surface.

At Truthdig, we don’t just report what's happening — we investigate how and why. We follow the threads others leave behind and uncover the forces shaping our future.

Your tax-deductible donation fuels journalism that asks harder questions and digs where others won’t.

Don’t settle for surface-level coverage.

Unearth what matters. Help dig deeper.

Donate now.

SUPPORT TRUTHDIG